drugset / Trial / NCT03529539
Expanded Access for PSV Personalized Oncolytic Viruses
Summary
A compassionate use, expanded access protocol for patients who have exhausted all standard therapy having progressed on chemotherapy and immunotherapy.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Personalized Virus | Other / unclassified | — | Intrathecal |